Topics

Janssen submits Spravato expansion in EU

05:56 EST 16 Jan 2020 | PharmaTimes

The J&J division seeks to expand the use to adults with major depressive disorder who have current suicidal ideation with intent.

Original Article: Janssen submits Spravato expansion in EU

NEXT ARTICLE

More From BioPortfolio on "Janssen submits Spravato expansion in EU"

Quick Search